You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

List of Excipients in API VALSARTAN


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing VALSARTAN

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Novartis Pharmaceuticals Corporation DIOVAN valsartan 0078-0423 CELLULOSE, MICROCRYSTALLINE
Novartis Pharmaceuticals Corporation DIOVAN valsartan 0078-0423 CROSPOVIDONE
Novartis Pharmaceuticals Corporation DIOVAN valsartan 0078-0423 FERRIC OXIDE YELLOW
Novartis Pharmaceuticals Corporation DIOVAN valsartan 0078-0423 HYPROMELLOSES
Novartis Pharmaceuticals Corporation DIOVAN valsartan 0078-0423 MAGNESIUM STEARATE
Novartis Pharmaceuticals Corporation DIOVAN valsartan 0078-0423 POLYETHYLENE GLYCOL 8000
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing VALSARTAN

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc valsartan 0378-5807 CROSPOVIDONE
Mylan Pharmaceuticals Inc valsartan 0378-5807 FERRIC OXIDE RED
Mylan Pharmaceuticals Inc valsartan 0378-5807 FERRIC OXIDE YELLOW
Mylan Pharmaceuticals Inc valsartan 0378-5807 HYPROMELLOSE
Mylan Pharmaceuticals Inc valsartan 0378-5807 LACTOSE MONOHYDRATE
Mylan Pharmaceuticals Inc valsartan 0378-5807 MAGNESIUM STEARATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for VALSARTAN

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BLUE 1

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CI 77891

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: CURRY RED

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

VALSARTAN drug variants containing FD&C BLUE NO. 2

Company Ingredient NDC
Unit Dose Services valsartan 50436-2168
Solco Healthcare US LLC valsartan and hydrochlorothiazide 43547-311
A-S Medication Solutions valsartan and hydrochlorothiazide 50090-7443
A-S Medication Solutions valsartan and hydrochlorothiazide 50090-7444
Northwind Pharmaceuticals LLC valsartan and hydrochlorothiazide 51655-243
Bryant Ranch Prepack valsartan and hydrochlorothiazide 71335-2200
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: FD&C RED NO. 40

VALSARTAN drug variants containing FD&C RED NO. 40

Company Ingredient NDC
AvKARE valsartan and hydrochlorothiazide 42291-965
A-S Medication Solutions valsartan and hydrochlorothiazide 50090-6232
Amneal Pharmaceuticals of New York LLC valsartan and hydrochlorothiazide 53746-845
DirectRX valsartan and hydrochlorothiazide 61919-634
Amneal Pharmaceuticals LLC valsartan and hydrochlorothiazide 65162-845
Preferred Pharmaceuticals Inc valsartan and hydrochlorothiazide 68788-8463
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: HEMATITE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: INDIGOTINDISULFONATE SODIUM

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: METHYLPARABEN

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: PEG-75

Excipient focus: POLOXAMER 188

Excipient focus: POLYDEXTROSE

VALSARTAN drug variants containing POLYDEXTROSE

Company Ingredient NDC
Mylan Pharmaceuticals Inc valsartan and hydrochlorothiazide 0378-6321
A-S Medication Solutions valsartan and hydrochlorothiazide 50090-5985
Northwind Pharmaceuticals LLC valsartan and hydrochlorothiazide 51655-243
Northwind Pharmaceuticals LLC valsartan and hydrochlorothiazide 51655-389
Preferred Pharmaceuticals Inc valsartan and hydrochlorothiazide 68788-7887
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

VALSARTAN drug variants containing POLYETHYLENE GLYCOL 400

Company Ingredient NDC
Marlex Pharmaceuticals Inc valsartan 10135-768
SQUARE PHARMACEUTICALS LIMITED valsartan 76483-026
Mylan Pharmaceuticals Inc valsartan and hydrochlorothiazide 0378-6321
Alembic Pharmaceuticals Limited valsartan and hydrochlorothiazide 46708-453
A-S Medication Solutions valsartan and hydrochlorothiazide 50090-3485
A-S Medication Solutions valsartan and hydrochlorothiazide 50090-4839
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYETHYLENE GLYCOL 4000

VALSARTAN drug variants containing POLYETHYLENE GLYCOL 4000

Company Ingredient NDC
Marlex Pharmaceuticals Inc valsartan 10135-768
Physicians Total Care Inc valsartan 54868-6458
Dr Reddy's Laboratories Limited valsartan 55111-731
SQUARE PHARMACEUTICALS LIMITED valsartan 76483-026
A-S Medication Solutions valsartan and hydrochlorothiazide 50090-1762
Northwind Pharmaceuticals valsartan and hydrochlorothiazide 51655-953
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

VALSARTAN drug variants containing POLYETHYLENE GLYCOLS

Company Ingredient NDC
Aphena Pharma Solutions - Tennessee LLC valsartan 43353-203
Northwind Pharmaceuticals valsartan 51655-751
Sandoz Inc valsartan and hydrochlorothiazide 0781-5948
Physicians Total Care Inc valsartan and hydrochlorothiazide 54868-4425
Physicians Total Care Inc valsartan and hydrochlorothiazide 54868-6440
DirectRX valsartan and hydrochlorothiazide 61919-634
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POTASSIUM SORBATE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K30

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SAND

Excipient focus: SILICA

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: SUCRALOSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

VALSARTAN drug variants containing TRIACETIN

Company Ingredient NDC
Mylan Pharmaceuticals Inc valsartan and hydrochlorothiazide 0378-6321
A-S Medication Solutions valsartan and hydrochlorothiazide 50090-5985
Northwind Pharmaceuticals LLC valsartan and hydrochlorothiazide 51655-243
Northwind Pharmaceuticals LLC valsartan and hydrochlorothiazide 51655-389
Preferred Pharmaceuticals Inc valsartan and hydrochlorothiazide 68788-7887
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: VANILLIN

Excipient focus: WATER

Excipient focus: YELLOW 6

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links